MeiraGTx Holdings plc
MGTX
Price:
$9.59
Market Cap:
$888.13M
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses. Its development efforts span a broad spectrum of conditions, encompassing ocular diseases like inherited forms of blindness, as well as xerostomia (dry mouth) that often follows radiation treatment for head and neck cancers. The company also targets various degenerative and neurodegenerative disorders, notably amyotrophic lateral sclerosis (ALS) and Parkinson's disease. Currently, several of its programs are in active clinical development, including Phase 1/2 trials for Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-defici...[Read more]
Industry
Biotechnology
IPO Date
2018-06-08
Stock Exchange
NASDAQ
Ticker
MGTX
PE Ratio
[-6.48]
ROE
[474.91%]
Current Ratio
[0.55]
Dividend Yield
[0%]
Enterprise Value
[904.12M]
Dividend History
The ROE as of June 2026 (TTM) for MeiraGTx Holdings plc (MGTX) is 474.91%
According to MeiraGTx Holdings plc’s latest financial reports and current stock price. The company's current ROE is 474.91%. This represents a change of -238.98% compared to the average of -341.72% of the last 4 quarters.
MeiraGTx Holdings plc (MGTX) Historical ROE (quarterly & annually)
How has MGTX ROE performed in the past?
The mean historical ROE of MeiraGTx Holdings plc over the last ten years is 156.37%. The current 474.91% ROE has changed 203.72% with respect to the historical average. Over the past ten years (40 quarters), MGTX's ROE was at its highest in in the September 2025 quarter at 124.55%. The ROE was at its lowest in in the June 2025 quarter at -1310.64%.
Average
156.37%
Median
-35.80%
Minimum
-217.89%
Maximum
1.97%
MeiraGTx Holdings plc (MGTX) ROE by Quarter and Year
Discovering the peaks and valleys of MeiraGTx Holdings plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 258.31%
Maximum Annual ROE = 1.97%
Minimum Annual Increase = -1004.73%
Minimum Annual ROE = -217.89%
| Year | ROE | Change |
|---|---|---|
| 2025 | 1.97% | -1004.73% |
| 2024 | -217.89% | 258.31% |
| 2023 | -60.81% | -44.76% |
| 2022 | -110.09% | 156.54% |
| 2021 | -42.91% | 76.53% |
| 2020 | -24.31% | -15.28% |
| 2019 | -28.69% | -71.93% |
| 2018 | -102.23% | -255.97% |
| 2017 | 65.54% | -42.35% |
MeiraGTx Holdings plc (MGTX) Average ROE
How has MGTX ROE performed in the past?
The current ROE of MeiraGTx Holdings plc (MGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
564.22%
5-year avg
307.93%
10-year avg
156.37%
MeiraGTx Holdings plc (MGTX) ROE vs. Peers
How is MGTX’s ROE compared to its peers?
MeiraGTx Holdings plc’s ROE is greater than ArriVent BioPharma, Inc. Common Stock (-48.98%), greater than MBX Biosciences, Inc. Common Stock (-24.50%), greater than Astria Therapeutics, Inc. (-45.01%), greater than Ginkgo Bioworks Holdings, Inc. (-57.31%), greater than Iovance Biotherapeutics, Inc. (-50.17%), greater than Erasca, Inc. (-77.01%), greater than MoonLake Immunotherapeutics (-85.61%), greater than Replimune Group, Inc. (-102.69%), greater than Arvinas, Inc. (-44.39%), greater than Absci Corporation (-63.58%),
| Company | ROE | Market cap |
|---|---|---|
| -48.98% | $1.42B | |
| -24.50% | $1.19B | |
| -45.01% | $718.13M | |
| -57.31% | $515.41M | |
| -50.17% | $1.46B | |
| -77.01% | $4.37B | |
| -85.61% | $1.38B | |
| -102.69% | $733.24M | |
| -44.39% | $489.07M | |
| -63.58% | $1.06B |
Build a custom stock screener for MeiraGTx Holdings plc (MGTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MeiraGTx Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
MeiraGTx Holdings plc (MGTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like MeiraGTx Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is MeiraGTx Holdings plc's ROE?
How is the ROE calculated for MeiraGTx Holdings plc (MGTX)?
What is the highest ROE for MeiraGTx Holdings plc (MGTX)?
What is the 3-year average ROE for MeiraGTx Holdings plc (MGTX)?
What is the 5-year average ROE for MeiraGTx Holdings plc (MGTX)?
How does the current ROE for MeiraGTx Holdings plc (MGTX) compare to its historical average?